AJIC: American Journal of Infection Control
Volume 30, Issue 8 , Pages 476-489 , December 2002

Guidelines for the prevention of intravascular catheter-related infections

References 

  1. Sherertz RJ, Ely EW, Westbrook DM, et al.  Education of physicians-in-training can decrease the risk for vascular catheter infection. Ann Intern Med. 2000;132:641–648
  2. Eggimann P, Harbarth S, Constantin MN, Touveneau S, Chevrolet JC, Pittet D. Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care. Lancet. 2000;355:1864–1868
  3. Nehme AE. Nutritional support of the hospitalized patient. The team concept. JAMA. 1980;243:1906–1908
  4. Soifer NE, Borzak S, Edlin BR, Weinstein RA. Prevention of peripheral venous catheter complications with an intravenous therapy team: a randomized controlled trial. Arch Intern Med. 1998;158:473–477
  5. Tomford JW, Hershey CO. The i.v. therapy team: impact on patient care and costs of hospitalization. NITA. 1985;8:387–389
  6. Davis D, O'Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?. JAMA. 1999;282:867–874
  7. Conly JM, Hill S, Ross J, Lertzman J, Louie TJ. Handwashing practices in an intensive care unit: the effects of an educational program and its relationship to infection rates. Am J Infect Control. 1989;17:330–339
  8. East SA. Planning, implementation, and evaluation of a successful hospital-based peripherally inserted central catheter program. J Intraven Nurs. 1994;17:189–192
  9. Kyle KS, Myers JS. Peripherally inserted central catheters. Development of a hospital-based program. J Intraven Nurs. 1990;13:287–290
  10. BeVier PA, Rice CE. Initiating a pediatric peripherally inserted central catheter and midline catheter program. J Intraven Nurs. 1994;17:201–205
  11. Tomford JW, Hershey CO, McLaren CE, Porter DK, Cohen DI. Intravenous therapy team and peripheral venous catheter-associated complications. A prospective controlled study. Arch Intern Med. 1984;144:1191–1194
  12. Wenzel RP, Wentzel RP. The development of academic programs for quality assessment. Arch Intern Med. 1991;151:653–654
  13. Fridkin SK, Pear SM, Williamson TH, Galgiani JN, Jarvis WR. The role of understaffing in central venous catheter-associated bloodstream infections. Infect Control Hosp Epidemiol. 1996;17:150–158
  14. Robert J, Fridkin SK, Blumberg HM, et al.  The influence of the composition of the nursing staff on primary bloodstream infection rates in a surgical intensive care unit. Infect Control Hosp Epidemiol. 2000;21:12–17
  15. Vicca AF. Nursing staff workload as a determinant of methicillin-resistant Staphylococcus aureus spread in an adult intensive therapy unit. J Hosp Infect. 1999;43:109–113
  16. Pearson ML. Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: an overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control. 1996;24:262–277
  17. White MC, Ragland KE. Surveillance of intravenous catheter-related infections among home care clients. Am J Infect Control. 1994;22:231–235
  18. Lorenzen AN, Itkin DJ. Surveillance of infection in home care. Am J Infect Control. 1992;20:326–329
  19. White MC. Infections and infection risks in home care settings. Infect Control Hosp Epidemiol. 1992;13:535–539
  20. Pittet D, Tarana D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271:1598–1601
  21. Raad , Baba M, Bodey GP. Diagnosis of catheter-related infections: the role of surveillance and targeted quantitative skin cultures. Clin Infect Dis. 1995;20:593–597
  22. Widmer AF, Nettleman M, Flint K, Wenzel RP. The clinical impact of culturing central venous catheters. A prospective study. Arch Intern Med. 1992;152:1299–1302
  23. Larson EL, Rackoff WR, Weiman M, et al.  APIC guideline for handwashing and hand antisepsis in health care settings. Am J Infect Control. 1995;23:251–269
  24. Boyce JM, Farr BM, Jarvis WR, et al.  Guideline for hand hygeine in the healthcare setting. Am J Infect Control. 2002; in press
  25. Bischoff WE, Reynolds TM, Sessler CN, Edmond MB, Wenzel RP. Handwashing compliance by health care workers: The impact of introducing an accessible, alcohol-based hand antiseptic. Arch Intern Med. 2000;160:1017–1021
  26. Pittet D, Dharan S, Touveneau S, Sauvan V, Perneger TV. Bacterial contamination of the hands of hospital staff during routine patient care. Arch Intern Med. 1999;159:821–826
  27. Simmons B, Bryant J, Neiman K, Spencer L, Arheart K. The role of handwashing in prevention of endemic intensive care unit infections. Infect Control Hosp Epidemiol. 1990;11:589–594
  28. Boyce JM, Kelliher S, Vallande N. Skin irritation and dryness associated with two hand-hygiene regimens: soap-and-water hand washing versus hand antisepsis with an alcoholic hand gel. Infect Control Hosp Epidemiol. 2000;21:442–448
  29. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med. 1991;91:197S–205S
  30. Raad , Hohn DC, Gilbreath BJ, et al.  Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994;15:231–238
  31. Capdevila JA. Catheter-related infection: an update on diagnosis, treatment, and prevention. Int J Infect Dis. 1998;2:230–236
  32. Abi-Said D, Raad I, Umphrey J, et al.  Infusion therapy team and dressing changes of central venous catheters. Infect Control Hosp Epidemiol. 1999;20:101–105
  33. Centers for Disease Control . Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B viurs, and other bloodbourne pathogens in health-care settings. MMWR. 1988;24:377–382
  34. Povoski SP. A prospective analysis of the cephalic vein cutdown approach for chronic indwelling central venous access in 100 consecutive cancer patients [In Process Citation]. Ann Surg Oncol. 2000;7:496–502
  35. Arrighi DA, Farnell MB, Mucha P, Iistrup DM, Anderson DL. Prospective, randomized trial of rapid venous access for patients in hypovolemic shock. Ann Emerg Med. 1989;18:927–930
  36. Ahmed Z, Mohyuddin Z. Complications associated with different insertion techniques for Hickman catheters. Postgrad Med J. 1998;74:104–107
  37. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339–343
  38. Garland JS, Buck RK, Maloney P, et al.  Comparison of 10% povidone-iodine and 0.5% chlorhexidine gluconate for the prevention of peripheral intravenous catheter colonization in neonates: a prospective trial. Pediatr Infect Dis J. 1995;14:510–516
  39. Little JR, Murray PR, Traynor PS, Spitznagel E. A randomized trial of povidone-iodine compared with iodine tincture for venipuncture site disinfection: effects on rates of blood culture contamination. Am J Med. 1999;107:119–125
  40. Mimoz O, Pieroni L, Lawrence C, et al.  Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients. Crit Care Med. 1996;24:1818–1823
  41. Maki DG, McCormack KN. Defatting catheter insertion sites in total parenteral nutrition is of no value as an infection control measure. Controlled clinical trial. Am J Med. 1987;83:833–840
  42. Maki DG, Stolz SS, Wheeler S, Mermel LA. A prospective, randomized trial of gauze and two polyurethane dressings for site care of pulmonary artery catheters: implications for catheter management. Crit Care Med. 1994;22:1729–1737
  43. Bijma R, Girbes AR, Kleijer DJ, Zwaveling JH. Preventing central venous catheter-related infection in a surgical intensive-care unit. Infect Control Hosp Epidemiol. 1999;20:618–620
  44. Rasero L, Degl'Innocenti M, Mocali M, et al.  Comparison of two different time interval protocols for central venous catheter dressing in bone marrow transplant patients: results of a randomized,multicenter study. Haematologica. 2000;85:275–279
  45. Madeo M, Martin CR, Turner C, Kirkby V, Thompson DR. A randomized trial comparing Arglaes (a transparent dressing containing silver ions) to Tegaderm (a transparent polyurethane dressing) for dressing peripheral arterial catheters and central vascular catheters. Intensive Crit Care Nurs. 1998;14:187–191
  46. Zakrzewska-Bode A, Muytjens HL, Liem KD, Hoogkamp-Korstanje JA. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J Hosp Infect. 1995;31:189–193
  47. Flowers RH, Schwenzer KJ, Kopel RF, Fisch MJ, Tucker SI, Farr BM. Efficacy of an attachable subcutaneous cuff for the prevention of intravascular catheter-related infection. A randomized, controlled trial. JAMA. 1989;261:878–883
  48. Robbins J, Cromwell P, Korones DN. Swimming and central venous catheter-related infections in the child with cancer. J Pediatr Oncol Nurs. 1999;16:51–56
  49. Howell PB, Walters PE, Donowitz GR, Farr BM. Risk factors for infection of adult patients with cancer who have tunnelled central venous catheters. Cancer. 1995;75:1367–1375
  50. Goetz AM, Wagener MM, Miller JM, Muder RR. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol. 1998;19:842–845
  51. Trottier SJ, Veremakis C, O'Brien J, Auer AI. Femoral deep vein thrombosis associated with central venous catheterization: results from a prospective, randomized trial. Crit Care Med. 1995;23:52–59
  52. Goetz AM, Miller J, Wagener MM, Muder RR. Complications related to intravenous midline catheter usage. A 2-year study. J Intraven Nurs. 1998;21:76–80
  53. Martin C, Viviand X, Saux P, Gouin F. Upper-extremity deep vein thrombosis after central venous catheterization via the axillary vein. Crit Care Med. 1999;27:2626–2629
  54. Robinson JF, Robinson WA, Cohn A, Garg K, Armstrong JD. Perforation of the great vessels during central venous line placement. Arch Intern Med. 1995;155:1225–1228
  55. Lederle FA, Parenti CM, Berskow LC, Ellingson KJ. The idle intravenous catheter. Ann Intern Med. 1992;116:737–738
  56. Parenti CM, Lederle FA, Impola CL, Peterson LR. Reduction of unnecessary intravenous catheter use. Internal medicine house staff participate in a successful quality improvement project. Arch Intern Med. 1994;154:1829–1832
  57. Cook D, Randolph A, Kernerman P, et al.  Central venous catheter replacement strategies: a systematic review of the literature. Crit Care Med. 1997;25:1417–1424
  58. Cobb DK, High KP, Sawyer RG, et al.  A controlled trial of scheduled replacement of central venous and pulmonary-artery catheters. N Engl J Med. 1992;327:1062–1068
  59. Thomas F, Burke JP, Parker J, et al.  The risk of infection related to radial vs femoral sites for arterial catheterization. Crit Care Med. 1983;11:807–812
  60. Lai KK. Safety of prolonging peripheral cannula and i.v. tubing use from 72 hours to 96 hours. Am J Infect Control. 1998;26:66–70
  61. Garland JS, Dunne WM, Havens P, et al.  Peripheral intravenous catheter complications in critically ill children: a prospective study. Pediatrics. 1992;89:1145–1150
  62. Garland JS, Nelson DB, Cheah TE, Hennes HH, Johnson TM. Infectious complications during peripheral intravenous therapy with Teflon catheters: a prospective study. Pediatr Infect Dis J. 1987;6:918–921
  63. Nelson DB, Garland JS. The natural history of Teflon catheter-associated phlebitis in children. Am J Dis Child. 1987;141:1090–1092
  64. Shimandle RB, Johnson D, Baker M, Stotland N, Karrison T, Arnow PM. Safety of peripheral intravenous catheters in children. Infect Control Hosp Epidemiol. 1999;20:736–740
  65. O'Grady NP, Barie PS, Bartlett J, et al.  Practice parameters for evaluating new fever in critically ill adult patients. Task Force of the American College of Critical Care Medicine of the Society of Critical Care Medicine in collaboration with the Infectious Disease Society of America. Crit Care Med. 1998;26:392–408 [see comments]
  66. Mermel LA, Farr BM, Sherertz RJ, et al.  Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32:1249–1272
  67. Sitges-Serra A, Linares J, Perez JL, Jaurrieta E, Lorente L. A randomized trial on the effect of tubing changes on hub contamination and catheter sepsis during parenteral nutrition. JPEN J Parenter Enteral Nutr. 1985;9:322–325
  68. Josephson A, Gombert ME, Sierra MF, Karanfil LV, Tansino GF. The relationship between intravenous fluid contamination and the frequency of tubing replacement. Infect Control. 1985;6:367–370
  69. Maki DG, Botticelli JT, LeRoy ML, Thielke TS. Prospective study of replacing administration sets for intravenous therapy at 48- vs 72-hour intervals. 72 hours is safe and cost-effective. JAMA. 1987;258:1777–1781
  70. Snydman DR, Donnelly-Reidy M, Perry LK, Martin WJ. Intravenous tubing containing burettes can be safely changed at 72 hour intervals. Infect Control. 1987;8:113–116
  71. Melly MA, Meng HC, Schaffner W. Microbiol growth in lipid emulsions used in parenteral nutrition. Arch Surg. 1975;110:1479–1481
  72. Mershon J, Nogami W, Williams JM, Yoder C, Eitzen HE, Lemons JA. Bacterial/fungal growth in a combined parenteral nutrition solution. JPEN J Parenter Enteral Nutr. 1986;10:498–502
  73. Gilbert M, Gallagher SC, Eads M, Elmore MF. Microbial growth patterns in a total parenteral nutrition formulation containing lipid emulsion. JPEN J Parenter Enteral Nutr. 1986;10:494–497
  74. Maki DG, Martin WT. Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusions. J Infect Dis. 1975;131:267–272
  75. Didier ME, Fischer S, Maki DG. Total nutrient admixtures appear safer than lipid emulsion alone as regards microbial contamination: growth properties of microbial pathogens at room temperature. J Parenter Enteral Nutr. 1998;22:291–296
  76. Bennett SN, McNeil MM, Bland LA, et al.  Postoperative infections traced to contamination of an intravenous anesthetic, propofol. N Engl J Med. 1995;333:147–154
  77. Arduino MJ, Bland LA, Danzig LE, McAllister SK, Aguero SM. Microbiologic evaluation of needleless and needle-access devices. Am J Infect Control. 1997;25:377–380
  78. Brown JD, Moss HA, Elliott TS. The potential for catheter microbial contamination from a needleless connector. J Hosp Infect. 1997;36:181–189
  79. Cookson ST, Ihrig M, O'Mara EM, et al.  Increased bloodstream infection rates in surgical patients associated with variation from recommended use and care following implementation of a needleless device. Infect Control Hosp Epidemiol. 1998;19:23–27
  80. Luebke MA, Arduino MJ, Duda DL, et al.  Comparison of the microbial barrier properties of a needleless and a conventional needle-based intravenous access system. Am J Infect Control. 1998;26:437–441
  81. McDonald LC, Banerjee SN, Jarvis WR. Line-associated bloodstream infections in pediatric intensive-care-unit patients associated with a needleless device and intermittent intravenous therapy. Infect Control Hosp Epidemiol. 1998;19:772–777
  82. Mendelson MH, Short LJ, Schechter CB, et al.  Study of a needleless intermittent intravenous-access system for peripheral infusions: analysis of staff, patient, and institutional outcomes. Infect Control Hosp Epidemiol. 1998;19:401–406
  83. Seymour VM, Dhallu TS, Moss HA, Tebbs SE, Elliot TS. A prospective clinical study to investigate the microbial contamination of a needleless connector. J Hosp Infect. 2000;45:165–168
  84. Do AN, Ray BJ, Banerjee SN, et al.  Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. J Infect Dis. 1999;179:442–448
  85. Crocker KS, Noga R, Filibeck DJ, Krey SH, Markovic M, Steffee WP. Microbial growth comparisons of five commercial parenteral lipid emulsions. J Parenter Enteral Nutr. 1984;8:391–395
  86. Jarvis WR, Highsmith AK. Bacterial growth and endotoxin production in lipid emulsion. J Clin Microbiol. 1984;19:17–20
  87. Roth VR, Arduino MJ, Nobiletti J, et al.  Transfusion-related sepsis due to Serratia liquefaciens in the United States. Transfusion. 2000;40:931–935
  88. Blajchman MA. Reducing the risk of bacterial contamination of cellular blood components. Dev Biol Stand. 2000;102:183–193
  89. Barrett BB, Andersen JW, Anderson KC. Strategies for the avoidance of bacterial contamination of blood components. Transfusion. 1993;33:228–233
  90. Wagner SJ, Friedman LI, Dodd RY. Transfusion-associated bacterial sepsis. Clin Microbiol Rev. 1994;7:290–302
  91. Plott RT, Wagner RF, Tyring SK. Iatrogenic contamination of multidose vials in simulated use. A reassessment of current patient injection technique. Arch Dermatol. 1990;126:1441–1444
  92. Salzman MB, Isenberg HD, Rubin LG. Use of disinfectants to reduce microbial contamination of hubs of vascular catheters. J Clin Microbiol. 1993;31:475–479
  93. ASHP Council on Professional Affairs . ASHP guidelines on quality assurance for pharmacy-prepared sterile products [In Process Citation]. Am J Health Syst Pharm. 2000;57:1150–1169
  94. Herruzo-Cabrera R, Garcia-Caballero J, Vera-Cortes ML, et al.  Growth of microorganisms in parenteral nutrient solutions. Am J Hosp Pharm. 1984;41:1178–1180
  95. Green KA, Mustachi B, Schoer K, Moro D, Blend R, McGeer A. Gadolinium-based MR contrast media: potential for growth of microbial contaminants when single vials are used for multiple patients. AJR Am J Roentgenol. 1995;165:669–671
  96. Arrington ME, Gabbert KC, Mazgaj PW, Wolf MT. Multidose vial contamination in anesthesia. Aana J. 1990;58:462–466
  97. Maddox RR, John JF, Brown LL, Smith CE. Effect of inline filtration on postinfusion phlebitis. Clin Pharm. 1983;2:58–61
  98. Falchuk KH, Peterson L, McNeil BJ. Microparticulate-induced phlebitis. Its prevention by in-line filtration. N Engl J Med. 1985;312:78–82
  99. Cohran J, Larson E, Roach H, Blane C, Pierce P. Effect of intravascular surveillance and education program on rates of nosocomial bloodstream infections. Heart Lung. 1996;25:161–164
  100. McKee R, Dunsmuir R, Whitby M, Garden OJ. Does antibiotic prophylaxis at the time of catheter insertion reduce the incidence of catheter-related sepsis in intravenous nutrition?. J Hosp Infect. 1985;6:419–425
  101. Ranson MR, Oppenheim BA, Jackson A, Kamthan AG, Scarffe JH. Double-blind placebo controlled study of vancomycin prophylaxis for central venous catheter insertion in cancer patients. J Hosp Infect. 1990;15:95–102
  102. Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol. 1996;17:811–813
  103. Netto dos Santos KR, de Souza Fonseca L, Gontijo Filho PP. Emergence of high-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from Brazilian university hospitals. Infect Control Hosp Epidemiol. 1996;17:813–816
  104. Band JD, Maki DG. Steel needles used for intravenous therapy. Morbidity in patients with hematologic malignancy. Arch Intern Med. 1980;140:31–34
  105. Tully JL, Friedland GH, Baldini LM, Goldmann DA. Complications of intravenous therapy with steel needles and Teflon catheters. A comparative study. Am J Med. 1981;70:702–706
  106. Ryder MA. Peripheral access options. Surg Oncol Clin N Am. 1995;4:395–427
  107. Maki DG, Goldman DA, Rhame FS. Infection control in intravenous therapy. Ann Intern Med. 1973;79:867–887
  108. Maki DG, Ringer M. Risk factors for infusion-related phlebitis with small peripheral venous catheters. A randomized controlled trial. Ann Intern Med. 1991;114:845–854
  109. Tager IB, Ginsberg MB, Ellis SE, et al.  An epidemiologic study of the risks associated with peripheral intravenous catheters. Am J Epidemiol. 1983;118:839–851
  110. Mermel LA, Parenteau S, Tow SM. The risk of midline catheterization in hospitalized patients. A prospective study. Ann Intern Med. 1995;123:841–844
  111. Centers for Disease Control . National Nosocomial Infections Surveillance (NNIS) System report, data summary from October 1986-April 1998, issued June 1998. Am J Infect Control. 1998;26:522–533
  112. Centers for Disease Control . National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control. 1999;27:520–532
  113. Banerjee SN, Emori TG, Culver DH, et al.  Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med. 1991;91:86S–89S
  114. Horan TC, Emori TG. Definitions of key terms used in the NNIS System. Am J Infect Control. 1997;25:112–116
  115. Khuri-Bulos NA, Shennak M, Agabi S, et al.  Nosocomial infections in the intensive care units at a university hospital in a developing country: comparison with National Nosocomial Infections Surveillance intensive care unit rates. Am J Infect Control. 1999;27:547–552
  116. Pittet D, Wenzel RP. Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths. Arch Intern Med. 1995;155:1177–1184
  117. Centers for Disease Control . Monitoring hospital-acquired infections to promote patient safety—United States, 1990-1999. MMWR Morb Mortal Wkly Rep. 2000;49:149–153
  118. Joint Commission on the Accreditation of Healthcare Organizations . Accreditation manual for hospitals. In: Joint Commission on the Accreditation of Healthcare Organizations, ed. Chicago , IL. 1994;p. 121–140
  119. Clark-Christoff N, Watters VA, Sparks W, Snyder P, Grant JP. Use of triple-lumen subclavian catheters for administration of total parenteral nutrition. J Parenter Enteral Nutr. 1992;16:403–407
  120. Early TF, Gregory RT, Wheeler JR, Snyder SO, Gayle RG. Increased infection rate in double-lumen versus single-lumen Hickman catheters in cancer patients. South Med J. 1990;83:34–36
  121. Hilton E, Haslett TM, Borenstein MT, Tucci V, Isenberg HD, Singer C. Central catheter infections: single- versus triple-lumen catheters. Influence of guide wires on infection rates when used for replacement of catheters. Am J Med. 1988;84:667–672
  122. Yeung C, May J, Hughes R. Infection rate for single lumen v triple lumen subclavian catheters. Infect Control Hosp Epidemiol. 1988;9:154–158
  123. Raad I, Darouiche R, Dupuis J, et al.  Central venous catheters coated with minocycline and rifampin for the prevention of catheter-related colonization and bloodstream infections. A randomized, double-blind trial. Ann Intern Med. 1997;127:267–274 The Texas Medical Center Catheter Study Group
  124. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA. 1999;281:261–267
  125. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med. 1997;127:257–266
  126. Veenstra DL, Saint S, Sullivan SD. Cost-effectiveness of antiseptic-impregnated central venous catheters for the prevention of catheter-related bloodstream infection. JAMA. 1999;282:554–560
  127. Darouiche RO, Raad , Heard SO, et al.  A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med. 1999;340:1–8 Catheter Study Group
  128. Collin GR. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest. 1999;115:1632–1640
  129. Groeger JS, Lucas AB, Thaler HT, et al.  Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med. 1993;119:1168–1174
  130. Pegues D, Axelrod P, McClarren C, et al.  Comparison of infections in Hickman and implanted port catheters in adult solid tumor patients. J Surg Oncol. 1992;49:156–162
  131. Foundation NK. III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. Am J Kidney Dis. 2001;37:S137–S181
  132. Moss AH, Vasilakis C, Holley JL, Foulks CJ, Pillai K, McDowell DE. Use of a silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney Dis. 1990;16:211–215
  133. Hoen B, Paul-Dauphin A, Hestin D, Kessler M. EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol. 1998;9:869–876
  134. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int. 1991;40:934–938
  135. Maki DG, Band JD. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med. 1981;70:739–744
  136. Merrer J, De Jonghe B, Golliot F, et al.  Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. Jama. 2001;286:700–707
  137. Venkataraman ST, Thompson AE, Orr RA. Femoral vascular catheterization in critically ill infants and children. Clin Pediatr (Phila). 1997;36:311–319
  138. Stenzel JP, Green TP, Fuhrman BP, Carlson PE, Marchessault RP. Percutaneous femoral venous catheterizations: a prospective study of complications. J Pediatr. 1989;114:411–415
  139. Goldstein AM, Weber JM, Sheridan RL. Femoral venous access is safe in burned children: an analysis of 224 catheters. J Pediatr. 1997;130:442–446
  140. Schillinger F, Schillinger D, Montagnac R, Milcent T. Post catheterisation vein stenosis in haemodialysis: comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephrol Dial Transplant. 1991;6:722–724
  141. Cimochowski GE, Worley E, Rutherford WE, Sartain J, Blondin J, Harter H. Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron. 1990;54:154–161
  142. Barrett N, Spencer S, McIvor J, Brown EA. Subclavian stenosis: a major complication of subclavian dialysis catheters. Nephrol Dial Transplant. 1988;3:423–425
  143. Trerotola SO, Kuhn-Fulton J, Johnson MS, Shah H, Ambrosius WT, Kneebone PH. Tunneled infusion catheters: increased incidence of symptomatic venous thrombosis after subclavian versus internal jugular venous access. Radiology. 2000;217:89–93
  144. Macdonald S, Watt AJ, McNally D, Edwards RD, Moss JG. Comparison of technical success and outcome of tunneled catheters inserted via the jugular and subclavian approaches. J Vasc Interv Radiol. 2000;11:225–231
  145. Cohen Y, Fosse JP, Karoubi P, et al.  The “hands-off” catheter and the prevention of systemic infections associated with pulmonary artery catheter: a prospective study. Am J Respir Crit Care Med. 1998;157:284–287
  146. Eyer S, Brummitt C, Crossley K, Siegel R, Cerra F. Catheter-related sepsis: prospective, randomized study of three methods of long-term catheter maintenance. Crit Care Med. 1990;18:1073–1079
  147. Widmer AF. Management of catheter-related bacteremia and fungemia in patients on total parenteral nutrition. Nutrition. 1997;13:18S–25S
  148. Powell C, Kudsk KA, Kulich PA, Mandelbaum JA, Fabri PJ. Effect of frequent guidewire changes on triple-lumen catheter sepsis. JPEN J Parenter Enteral Nutr. 1988;12:462–464
  149. Snydman DR, Murray SA, Kornfeld SJ, Majka JA, Ellis CA. Total parenteral nutrition-related infections. Prospective epidemiologic study using semiquantitative methods. Am J Med. 1982;73:695–699
  150. Henrickson KJ, Axtell RA, Hoover SM, et al.  Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial. J Clin Oncol. 2000;18:1269–1278
  151. Carratala J, Niubo J, Fernandez-Sevilla A, et al.  Randomized, double-blind trial of an antibiotic-lock technique for prevention of gram-positive central venous catheter-related infection in neutropenic patients with cancer. Antimicrob Agents Chemother. 1999;43:2200–2204
  152. Easom A. Prophylactic antibiotic lock therapy for hemodialysis catheters. Nephrol Nurs J. 2000;27:75
  153. Vercaigne LM, Sitar DS, Penner SB, Bernstein K, Wang GQ, Burczynski FJ. Antibiotic-heparin lock: in vitro antibiotic stability combined with heparin in a central venous catheter. Pharmacotherapy. 2000;20:394–399
  154. Maki DG, Ringer M. Evaluation of dressing regimens for prevention of infection with peripheral intravenous catheters. Gauze, a transparent polyurethane dressing, and an iodophor-transparent dressing. JAMA. 1987;258:2396–2403
  155. Garland JS, Alex CP, Mueller CD, et al.  A randomized trial comparing povidone-iodine to a chlorhexidine gluconateimpregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics. 2001;107:1431–1436
  156. Rao SP, Oreopoulos DG. Unusual complications of a polyurethane PD catheter. Perit Dial Int. 1997;17:410–412
  157. Riu S, Ruiz CG, Martinez-Vea A, Peralta C, Oliver JA. Spontaneous rupture of polyurethane peritoneal catheter. A possible deleterious effect of mupirocin ointment. Nephrol Dial Transplant. 1998;13:1870–1871
  158. Donowitz LG, Marsik FJ, Hoyt JW, Wenzel RP. Serratia marcescens bacteremia from contaminated pressure transducers. JAMA. 1979;242:1749–1751
  159. Luskin RL, Weinstein RA, Nathan C, Chamberlin WH, Kabins SA. Extended use of disposable pressure transducers. A bacteriologic evaluation. JAMA. 1986;255:916–920
  160. Maki DG, Hassemer CA. Endemic rate of fluid contamination and related septicemia in arterial pressure monitoring. Am J Med. 1981;70:733–738
  161. Mermel LA, Maki DG. Epidemic bloodstream infections from hemodynamic pressure monitoring: signs of the times. Infect Control Hosp Epidemiol. 1989;10:47–53
  162. Tenold R, Priano L, Kim K, Rourke B, Marrone T. Infection potential of nondisposable pressure transducers prepared prior to use. Crit Care Med. 1987;15:582–583
  163. Raad I, Umphrey J, Khan A, Truett LJ, Bodey GP. The duration of placement as a predictor of peripheral and pulmonary arterial catheter infections. J Hosp Infect. 1993;23:17–26
  164. Leroy O, Billiau V, Beuscart C, et al.  Nosocomial infections associated with long-term radial artery cannulation. Intensive Care Med. 1989;15:241–246
  165. Fisher MC, Long SS, Roberts EM, Dunn JM, Balsara RK. Pseudomonas maltophilia bacteremia in children undergoing open heart surgery. JAMA. 1981;246:1571–1574
  166. Stamm WE, Colella JJ, Anderson RL, Dixon RE. Indwelling arterial catheters as a source of nosocomial bacteremia. An outbreak caused by Flavobacterium Species. N Engl J Med. 1975;292:1099–1102
  167. Weinstein RA, Emori TG, Anderson RL, Stamm WE. Pressure transducers as a source of bacteremia after open heart surgery. Report of an outbreak and guidelines for prevention. Chest. 1976;69:338–344
  168. Shinozaki T, Deane RS, Mazuzan JE, Hamel AJ, Hazelton D. Bacterial contamination of arterial lines. A prospective study. JAMA. 1983;249:223–225
  169. Solomon SL, Alexander H, Eley JW, et al.  Nosocomial fungemia in neonates associated with intravascular pressure-monitoring devices. Pediatr Infect Dis. 1986;5:680–685
  170. Weems JJ, Chamberland ME, Ward J, Willy M, Padhye AA, Solomon SL. Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol. 1987;25:1029–1032
  171. Beck-Sague CM, Jarvis WR, Brook JH, et al.  Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. Am J Epidemiol. 1990;132:723–733
  172. Villarino ME, Jarvis WR, O'Hara C, Bresnahan J, Clark N. Epidemic of Serratia marcescens bacteremia in a cardiac intensive care unit. J Clin Microbiol. 1989;27:2433–2436
  173. Boo NY, Wong NC, Zulkifli SS, Lye MS. Risk factors associated with umbilical vascular catheter-associated thrombosis in newborn infants. J Paediatr Child Health. 1999;35:460–465
  174. Krauss AN, Albert RF, Kannan MM. Contamination of umbilical catheters in the newborn infant. J Pediatr. 1970;77:965–969
  175. Landers S, Moise AA, Fraley JK, Smith EO, Baker CJ. Factors associated with umbilical catheter-related sepsis in neonates. Am J Dis Child. 1991;145:675–680
  176. Cronin WA, Germanson TP, Donowitz LG. Intravascular catheter colonization and related bloodstream infection in critically ill neonates. Infect Control Hosp Epidemiol. 1990;11:301–308
  177. Miller KL, Coen PE, White WJ, Hurst WJ, Achey BE, Lang CM. Effectiveness of skin absorption of tincture of I in blocking radioiodine from the human thyroid gland. Health Phys. 1989;56:911–914
  178. Ankola PA, Atakent YS. Effect of adding heparin in very low concentration to the infusate to prolong the patency of umbilical artery catheters. Am J Perinatol. 1993;10:229–232
  179. Horgan MJ, Bartoletti A, Polansky S, Peters JC, Manning TJ, Lamont BM. Effect of heparin infusates in umbilical arterial catheters on frequency of thrombotic complications. J Pediatr. 1987;111:774–778
  180. David RJ, Merten DF, Anderson JC, Gross S. Prevention of umbilical artery catheter clots with heparinized infusates. Dev Pharmacol Ther. 1981;2:117–126
  181. Fletcher MA, Brown DR, Landers S, Seguin J. Umbilical arterial catheter use: report of an audit conducted by the Study Group for Complications of Perinatal Care. Am J Perinatol. 1994;11:94–99
  182. Seguin J, Fletcher MA, Landers S, Brown D, Macpherson T. Umbilical venous catheterizations: audit by the Study Group for Complications of Perinatal Care. Am J Perinatol. 1994;11:67–70
  183. Loisel DB, Smith MM, MacDonald MG, Martin GR. Intravenous access in newborn infants: impact of extended umbilical venous catheter use on requirement for peripheral venous lines. J Perinatol. 1996;16:461–466

☆ *See list at end of article.

☆☆ This article is being published simultaneously in American Journal of Infection Control and Infection Control and Hospital Epidemiology . The full text of the Guidelines for the Prevention of Intravascular Catheter-Related Infections was published in the Morbidity and Mortality Weekly Report 2002; 51 (No. RR-10) and can be accessed at www.cdc.gov/ncidod/hip/default.htm .

PII: S0196-6553(02)00250-X

doi: 10.1067/mic.2002.129427

AJIC: American Journal of Infection Control
Volume 30, Issue 8 , Pages 476-489 , December 2002

Article Tools